Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

U.S. Physical Therapy (USPH)

U.S. Physical Therapy (USPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

U.S. Physical Therapy 1300 WEST SAM HOUSTON PARKWAY SUITE 300 HOUSTON TX 77042 USA

P: 713-297-7000 F: 713-297-7090

Description:

U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.

Key Statistics

Overview:

Market Capitalization, $K 1,198,491
Shares Outstanding, K 12,912
Annual Sales, $ 422,970 K
Annual Net Income, $ 35,190 K
Last Quarter Sales, $ 125,890 K
Last Quarter Net Income, $ 10,010 K
60-Month Beta 1.42
% of Insider Shareholders 1.80%
% of Institutional Shareholders 97.93%
Float, K 12,680
% Float 98.20%

Growth:

1-Year Return -30.21%
3-Year Return -12.71%
5-Year Return 29.91%
5-Year Revenue Growth 27.67%
5-Year Earnings Growth 68.93%
5-Year Dividend Growth -46.67%

Per-Share Information:

Most Recent Earnings 0.85 on 11/04/21
Next Earnings Date 02/24/22
Earnings Per Share ttm 3.53
EPS Growth vs. Prev Qtr -11.46%
EPS Growth vs. Prev Year -1.16%
Annual Dividend Rate, $ 1.52
Annual Dividend Yield 1.63%
Most Recent Dividend 0.380 on 11/12/21
Next Ex-Dividends Date 11/12/21
Dividend Payable Date 12/10/21
Dividend Payout Ratio 29.62%
Most Recent Split 3-2 on 06/29/01

USPH Ratios

Ratio
Price/Earnings ttm 26.46
Price/Earnings forward 45.58
Price/Earnings to Growth N/A
Return-on-Equity % 16.63%
Return-on-Assets % 7.69%
Profit Margin % 8.32
Net Margin % 7.46
Debt/Equity 0.12
Price/Sales 2.48
Price/Cash Flow 24.51
Price/Book 4.15
Book Value/Share 22.51
Interest Coverage 41.19

USPH Dividends

Date Value
11/12/21 $0.3800
08/19/21 $0.3800
05/13/21 $0.3500
03/11/21 $0.3500
03/12/20 $0.3200
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar